Remarkably, we have observed significant differences between healthy patients and IV stage CRC in the case of CXCL5 and CXCL16, which may suggest its involvement in distant metastasis processes and what is of utmost importance, significant differences between all CRC stages (same as CA 19–9). This evidence concerns the gene CXCL5 and colorectal carcinoma.